<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01396798</url>
  </required_header>
  <id_info>
    <org_study_id>S52996</org_study_id>
    <nct_id>NCT01396798</nct_id>
  </id_info>
  <brief_title>Validation of Vital Signs and Symptoms for the Diagnosis of Serious Infections in Children in the Paediatric A&amp;E.</brief_title>
  <acronym>ERNIE3</acronym>
  <official_title>Validation of Vital Signs and Symptoms for the Diagnosis of Serious Infections in Children in a High Prevalent Setting: the Paediatric A&amp;E.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Validation of Vital Signs and Symptoms for the Diagnosis of Serious Infections in Acutely Ill
      Children in a High Prevalent Setting: The Paediatric Accidents &amp; Emergencies through
      prospective observational data collection concerning specific items from the clinical and
      technical examination in diagnosing serious infections, such as meningitis, sepsis,
      pneumonia, pyelonephritis, bronchiolitis with hypoxia. Eventually we will attempt to validate
      a vital signs and symptoms rule derived from multiple low to high prevalent settings of
      acutely ill children.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>serious infections: meningitis, sepsis, pneumonia, pyelonephritis, osteomyelitis and cellulitis, gastroenteritis with sever dehydration, complicated urinary tract infection and complicated viral airway infection with hypoxia.</measure>
    <time_frame>within 24 hours after assessment</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1500</enrollment>
  <condition>Community-Acquired Infections</condition>
  <condition>Respiratory Tract Infections</condition>
  <condition>Sepsis</condition>
  <condition>Urinary Tract Infections</condition>
  <condition>Meningitis</condition>
  <condition>Gastroenteritis</condition>
  <arm_group>
    <arm_group_label>Children with an acute illness</arm_group_label>
    <description>Children aged 1 month to 16 years of age, which attend the A&amp;E department of UZLeuven with an acute illness episode of maximum 5 days.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Children aged 1 month to 16 years, attending the A&amp;E department of the UZLeuven Hospital
        with an acute illness episode of maximum 5 days
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 1 month to 16 years

          -  Acute illness episode of maximum 5 days

        Exclusion Criteria:

          -  recent trauma

          -  neurological conditions

          -  intoxication

          -  psychiatric of behavioural disorders without a somatic cause

          -  acute exacerbation of a chronic condition (asthma, known immunodeficiency, diabetes,
             cystic fibrosis, etc)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan YJ Verbakel, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Katholieke Universiteit Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dienst Algemene Kindergeneeskunde, Universitaire Ziekenhuizen Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Van den Bruel A, Haj-Hassan T, Thompson M, Buntinx F, Mant D; European Research Network on Recognising Serious Infection investigators. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet. 2010 Mar 6;375(9717):834-45. doi: 10.1016/S0140-6736(09)62000-6. Epub 2010 Feb 2. Review.</citation>
    <PMID>20132979</PMID>
  </reference>
  <reference>
    <citation>Van den Bruel A, Aertgeerts B, Bruyninckx R, Aerts M, Buntinx F. Signs and symptoms for diagnosis of serious infections in children: a prospective study in primary care. Br J Gen Pract. 2007 Jul;57(540):538-46.</citation>
    <PMID>17727746</PMID>
  </reference>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2011</study_first_submitted>
  <study_first_submitted_qc>July 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2011</study_first_posted>
  <last_update_submitted>September 13, 2012</last_update_submitted>
  <last_update_submitted_qc>September 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Jan Verbakel</investigator_full_name>
    <investigator_title>Jan Verbakel, M.D.</investigator_title>
  </responsible_party>
  <keyword>serious infections</keyword>
  <keyword>meningitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
    <mesh_term>Meningitis</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
    <mesh_term>Gastroenteritis</mesh_term>
    <mesh_term>Signs and Symptoms</mesh_term>
    <mesh_term>Community-Acquired Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

